Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial

HIGHLIGHTS

• What: In the trial , the authors chose it as the primary outcome for the reason that it has been regarded as the most sensitive and stable ERG marker for RP.30 A majority of previous studies on natural decay of RP and assessment of treatment efficacy were all based on this index . Study design and oversight This nonrandomized controlled trial was designed to evaluate the efficacy of minocycline in the treatment of RP, with full-field electroretinography (ffERG, shorted as ERG) as the primary efficacy outcome.
• Who: Yuxi Chen from the Study design and oversight . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.